Daiichi Sankyo (OTCMKTS:DSNKY) Shares Up 2.7% – Here’s Why

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) shares shot up 2.7% on Friday . The company traded as high as $21.99 and last traded at $21.99. 5,281 shares changed hands during trading, a decline of 98% from the average session volume of 259,104 shares. The stock had previously closed at $21.42.

Wall Street Analysts Forecast Growth

Separately, Zacks Research cut Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Price Performance

The company has a market capitalization of $41.37 billion and a PE ratio of 20.60. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06. The company’s 50 day moving average price is $23.22 and its 200-day moving average price is $23.86.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.